Literature DB >> 8702926

Analysis of M phase-specific phosphorylation of DNA topoisomerase II.

K Kimura1, N Nozaki, T Enomoto, M Tanaka, A Kikuchi.   

Abstract

In mammalian cells, two isoforms of DNA topoisomerase II (topo II), topo IIalpha and topo IIbeta, are phosphorylated. The phosphorylation of topo IIbeta changes its apparent molecular mass determined by SDS-polyacrylamide gel electrophoresis from 180 to 190 kDa in mitotic cells, whereas topo IIalpha affects it only slightly (Kimura, K., Nozaki, N., Saijo, M., Kikuchi, A., Ui, M., and Enomoto, T. (1994) J. Biol. Chem. 269, 24523-24526). Here we examined the stability of the protein and the phosphate moiety of each topo II isoform, as the cells progressed from M to G1 phase. While its protein moiety remained intact, 75% of the phosphates attached to topo IIbeta were removed within 4 h after release from mitotic block. On the other hand, 35% of topo IIalpha protein and 52% of the attached phosphates disappeared. We verified that M phase-specific phosphorylation had no particular effect on the catalytic activities of both topo II isoforms after extensive phosphatase digestion. We also examined the binding of two isoforms to the nucleus or chromosomes. In logarithmically growing cells, both isoforms were extracted from nuclei at the same concentrations of NaCl. From the mitotic chromosomes, topo IIbeta was extracted at much lower concentrations of NaCl than topo IIalpha.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702926     DOI: 10.1074/jbc.271.35.21439

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Proteomic analysis of human metaphase chromosomes reveals topoisomerase II alpha as an Aurora B substrate.

Authors:  Ciaran Morrison; Alexander J Henzing; Ole Nørregaard Jensen; Neil Osheroff; Helen Dodson; Stefanie E Kandels-Lewis; Richard R Adams; William C Earnshaw
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 2.  Topoisomerase II: untangling its contribution at the centromere.

Authors:  Andrew C G Porter; Christine J Farr
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

3.  Chromosome breakage is regulated by the interaction of the BLM helicase and topoisomerase IIalpha.

Authors:  Beatriz Russell; Saumitri Bhattacharyya; Jeremy Keirsey; April Sandy; Patrick Grierson; Erin Perchiniak; Juraj Kavecansky; Samir Acharya; Joanna Groden
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

4.  Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.

Authors:  P S Shapiro; A M Whalen; N S Tolwinski; J Wilsbacher; S J Froelich-Ammon; M Garcia; N Osheroff; N G Ahn
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.

Authors:  Atsushi Kitamura; Kazuyuki Matsushita; Yuichi Takiguchi; Hideaki Shimada; Yuji Tada; Makako Yamanaka; Kenzo Hiroshima; Masatoshi Tagawa; Takeshi Tomonaga; Hisahiro Matsubara; Makoto Inoue; Mamoru Hasegawa; Yasunori Sato; David Levens; Koichiro Tatsumi; Fumio Nomura
Journal:  Cancer Sci       Date:  2011-05-09       Impact factor: 6.716

6.  SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.

Authors:  Kazuyuki Matsushita; Toshiko Kajiwara; Mai Tamura; Mamoru Satoh; Nobuko Tanaka; Takeshi Tomonaga; Hisahiro Matsubara; Hideaki Shimada; Rei Yoshimoto; Akihiro Ito; Shuji Kubo; Tohru Natsume; David Levens; Minoru Yoshida; Fumio Nomura
Journal:  Mol Cancer Res       Date:  2012-04-11       Impact factor: 5.852

7.  The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype.

Authors:  Mitsuru Okuwaki; Masafumi Tsujimoto; Kyosuke Nagata
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

8.  Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle.

Authors:  P Muñoz; M Z Zdzienicka; J M Blanchard; J Piette
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  Survey for human polyomaviruses in cancer.

Authors:  Tuna Toptan; Samuel A Yousem; Jonhan Ho; Yuki Matsushima; Laura P Stabile; Maria-Teresa Fernández-Figueras; Rohit Bhargava; Akihide Ryo; Patrick S Moore; Yuan Chang
Journal:  JCI Insight       Date:  2016-02-25

10.  Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.

Authors:  M Kano; K Matsushita; B Rahmutulla; S Yamada; H Shimada; S Kubo; T Hiwasa; H Matsubara; F Nomura
Journal:  Gene Ther       Date:  2015-08-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.